Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 5 of 5 citing Noyan-Ashraf: GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes.... (0.10 sec) 

Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential …


DJ Grieve, RS Cassidy, BD Green - British Journal of Pharmacology, 2009 - interscience.wiley.com
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by the small
intestine in response to nutrient ingestion. It has wide-ranging effects on
glucose metabolism, including stimulation of insulin release, inhibition of ...
Cited by 1 - Related articles - All 3 versions

[PDF] Liraglutide in type 2 diabetes: from pharmacological development to clinical practice.


MC Rossi, A Nicolucci - Acta bio-medica: Atenei Parmensis, 2009 - actabiomedica.it
Type 2 diabetes mellitus (T2DM) is a global epi- demic and a leading cause of
morbidity and mortality that places a substantial economic and health burden on
the public (1). Successful management of T2DM requires strict control of ...
Related articles - View as HTML - All 2 versions

Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R …


U Kielgast, JJ Holst, S Madsbad - Current Diabetes Reviews, 2009 - ingentaconnect.com
Page 1. 266 Current Diabetes Reviews, 2009, 5, 266-275 1573-3998/09
$55.00+.00 © 2009 Bentham Science Publishers Ltd. Treatment ...

Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a …


J Kristensen, UM Mortensen, M Schmidt, PH … - BMC Cardiovascular Disorders, 2009 - biomedcentral.com
Danish Landrace Pigs (70–80 kg) were randomly assigned to Liraglutide (10
μg/kg) or control treatment given daily for three days before
ischemia-reperfusion. Ischemia was induced by balloon occlusion of the left ...
Related articles - Cached - All 6 versions

Liraglutide: A Review of its Use in Type 2 Diabetes Mellitus

- adisonline.com
KF Croom, PL McCormack - Drugs, 2009 - ingentaconnect.com
Various sections of the manuscript reviewed by: BW Bode, Atlanta Diabetes
Associates, Atlanta, Georgia, USA; RK Campbell, College of Pharmacy, Washington
State University, Pullman, Washington, USA; D. Hinnen, Mid America Diabetes ...
Related articles - All 5 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google